Anemia is a global public health problem in both developing and developed countries and has serious implications for human health. which affects a quarter of the world's population, data from the Laosu Health Center found that pregnant women in the first trimester who experienced anemia in 2017 were 68 (53.96%) cases of 126 target pregnant women, in 2018 there were 71 cases out of 127 targets (55.90%) of mothers pregnant, and in 2019 there were 74 (56.48%) cases of 131 target pregnant women. In 2020, periodically from January to August, 75 visits were found with pregnant women in the first trimester and in September new visits from pregnant women with anemia cases in the first trimester were found to be 33 (44%) pregnant women. The aim of the study to see the effect of giving blood supplemented tablets on hemoglobin levels in pregnant women in the first trimester at the Laosu Health Center, Konawe Regency. This study used a semi-experimental research method. The research design used was one pre-test and one post-test design. This research was conducted at the Laosu Public Health Center, Konawe Regency. This research will be conducted in November 2020. There is a significant influence between the dependent and independent variables, namely the effect of giving FE tablets with HB levels in pregnant women in the first trimester of the Laosu Health Center, Konawe Regency. There was a significant difference between first trimester pregnant women who were given Fe tablet treatment and first trimester pregnant women who were not given Fe tablets. There is an effect of offering blood-added tablets on the increase in hemoglobin levels in pregnant women in the first trimester in the work area of the laosu health center, Konawe district.

FE Tablets, HB Levels, Pregnant Women in Trimester I